Please assess the completion status of the following clinical trial:

Trial Title: Glucose Oxidase as Treatment Against Common Cold

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Symptoms of a common cold within the last 24 hours~Exclusion Criteria:~* Use of a nasal steroid due to allergy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Saline+glucose (Type: PLACEBO_COMPARATOR): A nasal spray with isotone saline + 5% glucose in a bag-on-valve nasal spray device. The spray will be administered with one puff in each nostril 5 times day one and thereafter trice daily for a total treatment time of one week
- Glucose oxidase + glucose (Type: ACTIVE_COMPARATOR): A nasal spray (bag-on-valve device) with 200U/ml glucose oxidase + 5% glucose in isotone saline. One puff in each nostril 5 times daily day one and 3 times daily thereafter. A total treatment time of one week.

Based on this trial design, predict the completion outcome and termination type (if applicable).